The Food and Drugs Authority (FDA) in the Ashanti Region has shut down a factory belonging to Unni Associates Company Limited for resuming the production of Arcan Bitters in defiance of a standing closure order. The regulatory body moved in after discovering that the company had continued operations at a second site despite being directed to stop all production activities. This enforcement action is part of the FDA's mandate to protect public health from unregistered and potentially hazardous products.
The controversy surrounding Arcan Bitters began in September, when the FDA first ordered the factory to close. Laboratory analysis of the beverage revealed it was contaminated with Sildenafil Citrate, an undeclared prescription drug used to treat erectile dysfunction. The inclusion of such a substance in a food or drink product is prohibited under the Public Health Act, as it can cause serious adverse health effects, including heart failure or dangerously low blood pressure, especially when consumed without medical supervision or in combination with other substances.
During the latest raid, FDA officials seized 23 barrels of alcoholic liquid, 1,500 boxes of the finished beverage, and 5,000 empty bottles meant for packaging. The regulator indicated that these items would be held as evidence as they pursue legal action against the company’s management. The FDA is also working closely with the police to apprehend the owner of the company, who is currently sought for violating the previous regulatory order and endangering the public.
The public has been strongly advised to avoid Arcan Bitters and to report any vendors still selling the product to the nearest FDA office. The authority reiterated its commitment to ensuring that all food and medicinal products on the Ghanaian market meet strict safety and quality standards. This closure serves as a warning to other manufacturers that the regulator will not tolerate the illegal production of adulterated goods that put the lives of citizens at risk.